This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) for therapeutic drugs. Its chiral structure makes it valuable in the production of enantiomerically pure compounds, which are crucial for drugs targeting specific biological pathways. It is often employed in the preparation of β-amino alcohols, which serve as key building blocks in the synthesis of beta-blockers and other cardiovascular medications. Additionally, its bromo-phenyl group allows for further functionalization, enabling the creation of diverse chemical structures for drug discovery and development. The compound is also explored in research for its potential use in neurological and psychiatric treatments due to its structural similarity to certain neurotransmitters.